Abstract:BACKGROUND & OBJECTIVE:More and more studies indicated that microenvironment plays a major role in growth, survival, and drug resistance of myeloma cells. Thalidomide is one of agents targeting the bone marrow microenvironment. This study was conducted to investigate the mechanism of thalidomide by observation of influence of thalidomide on bone marrow microenvironment in refractory and relapsed multiple myeloma. METHODS:The expression of ICAM-1 and VCAM-1 of bone marrow stromal cell (BMSC) membrane of refractory and relapsed multiple myeloma was measured using flow cytometry. The expression of IL-1beta(m)RNA, IL-6mRNA, and TNF-alpha(m)RNA in myeloma BMSC was measured by semiquantitative RT-PCR. The serum levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor(bFGF) were measured by ELISA. RESULTS:The average values of fluorescence of ICAM-1 and VCAM-1 on the myeloma BMSC membrane were 13.28+/-4.26 and 10.35+/-2.47, respectively; while the average values of fluorescence after treatment effectively with thalidomide were both lower (4.29+/-0.98 and 3.54+/-0.62) (P< 0.01, P< 0.05). The ratios of IL-1beta(m)RNA, IL-6(m)RNA, and TNF-alpha mRNA to beta-actin of the myeloma BMSC were 1.83+/-0.64, 24.52+/-11.46, and 3.42+/-1.83, respectively; while the ratios after treatment effectively with thalidomide were all lower (0.58+/-0.11, 13.47+/-14.31, and 1.25+/-0.76)(P< 0.05,P< 0.05,P< 0.01). There was no significant difference between the values of ICAM-1 and VCAM-1 or among the ratios of IL-1beta(m)RNA, IL-6(m)RNA, and TNF-amRNA to beta-actin of the myeloma BMSC before and after treatment ineffectively with thalidomide (all P >0.05). The serum levels of VEGF and bFGF of the patients were (150.26+/-19.33) ng/L and (23.78+/-13.63) ng/L, respectively. The serum levels of VEGF and bFGF were higher after treatment (effectively and ineffectively) than those before treatment (P< 0.002, P< 0.005). CONCLUSION:Thalidomide can not only inhibit angiogenesis, but also abrogate the adhesion of multiple myeloma cells to bone marrow stromal cells.

The study of thalidomide affecting VEGF of non-Hodgkin lymphoma Raji cells

Effects Of Thalidomide On The Expression Of Angiogenesis Growth Factors In Human A(549) Lung Adenocarcinoma Cells

Effects of thalidomide on angiogenesis and tumor growth and metastasis of human hepatocellular carcinoma in nude mice.

Study on in vitro effects and mechanism of Thalidomide on prostate cancer cell line PC-3

Effects of Thalidomide on Vascular Endothelial Growth Factors Expression in Endometrial Stromal Cells of Endometriosis in Vitro

Study of Thalidomide on the Growth and Angiogenesis of Ovary Cancer SKOV3 Transplanted Subcutaneously in Nude Mice

The Study on the Mechanism of Enhanced Radio-Sensitivity of Glioma Cell U251 by Thalidomide

Effect of Clinical Efficacy of Thalidomide Combined with Chemother-apy in Patients with Acute Leukemia and Angiogenesis Regulatory Factor

EFFECT OF THALIDOMIDE ON HEPATOCYTE CELL LINE SMMC-7721 HUMAN LIVER CANCER MODEL IN MICE

The Effect of Thalidomide on Serum VEGF、bFGF and TNF-α in Patients with Non-Small Cell Lung Cancer and Their Clinical Significance

Effect of Thalidomide on the Expressions of Vascular Endothelial Growth Factor in Human Lung Adenocarcinoma Cell Line

[Positive Immunoregulation of Thalidomide on Human Peripheral Blood Mononuclear Cell Cultures].

[Antiangiogenic Activity of Thalidomide in Vitro Mediated by Cytochrome CYP2C19].

Influence of Thalidomide on Bone Marrow Microenvironment in Refractory and Relapsed Multiple Myeloma

Thalidomide Inhibits Leukemia Cell Invasion and Migration by Upregulation of Early Growth Response Gene 1

The Effects of Thalidomide on Proliferation of Endothelial Cells of Human Umbilical Vein and Angiogenesis

[In Vitro Inhibition and Mechanism of Multiple Myeloma Cells Growth by Thalidomide].

Research Progress of Thalidomide in Usual Non-Hematologic Malignancies

Clinical study of effects of thalidomide on cytokines in patients with multiple myeloma

[Effects of Thalidomide on Annexin II Gene Regulation].

Mechanism Study of Thalidomide Regulating Angiogenesis in Lewis Lung Cancr Model